Contraception
Volume 75, Issue 1 , Pages 16-22, January 2007

Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg (Loestrin® 24 Fe)

This work was presented in abstract form in two publications [Abstract P-53 (Fertil Steril 2005;84:S169–S170) and Abstract P-56 (Fertil Steril 2005;84:S171)] at the 61st Annual Meeting of the American Society for Reproductive Medicine, Montreal, Quebec, Canada.

  • Steven T. Nakajima

      Affiliations

    • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Women's Health, University of Louisville, Louisville, KY 40202, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 502 629 2441; fax: +1 502 629 2444.
    • ,
  • David F. Archer

      Affiliations

    • CONRAD Clinical Research Center, The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, VA 23507, USA
    • ,
  • Herman Ellman

      Affiliations

    • Warner Chilcott Inc., Clinical Development, Rockaway, NJ 07866, USA

Received 15 May 2006; received in revised form 1 July 2006; accepted 2 August 2006. published online 21 September 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0010-7824(06)00317-9

doi:10.1016/j.contraception.2006.08.004

Contraception
Volume 75, Issue 1 , Pages 16-22, January 2007

Article Tools

* Image Usage & Resolution